David P Rotella

Title: David P. Rotella: Innovator in Pharmaceutical Chemistry

Introduction

David P. Rotella is a notable inventor based in State College, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work focuses on enhancing the efficacy and safety of antineoplastic agents.

Latest Patents

Rotella's latest patents include innovative diastereomeric mono- and di-substituted diamino cyclohexane compounds. One aspect of this invention relates to a process for making cyclohexane-1,2-di(O)-4,5-di(N) diastereomers, which serve as synthons for various diastereoisomeric pharmaceutical systems. The invention also encompasses stereoisomer compounds derived from retro-synthetic analysis. Additionally, it introduces novel antineoplastic Pt(II) complexes derived from these stereoisomers, which are designed to be less nephrotoxic than traditional agents like cisplatin. The enhanced water solubility of these complexes facilitates intravenous administration, making them a promising option for cancer treatment.

Career Highlights

David P. Rotella is affiliated with The Ohio State University, where he continues to advance research in pharmaceutical chemistry. His work has garnered attention for its potential to improve cancer therapies and reduce side effects associated with existing treatments.

Collaborations

One of his notable collaborators is Donald T. Witiak, with whom he has worked on various research projects aimed at developing innovative pharmaceutical solutions.

Conclusion

David P. Rotella's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. His patents reflect a commitment to improving cancer treatment options through the development of novel compounds.